NCT02749474Recruiting
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 13 Apr 2016
- Start date
- 1 Jul 2003
- Primary completion date
- 30 Jul 2028
- Lead sponsor
- The Cooper Health System
- Diseases
- Childhood cancers
- NCT number
- NCT02749474
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Jul 2003 to the primary completion date, 30 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Women diagnosed with cancer more than 6 months after the end of a pregnancy.
Who the study is looking for
- Any pregnant woman diagnosed with cancer within 6 weeks before her last menstrual period or 6 months after her end of pregnancy either by delivery or miscarriage.
Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cooper University Hospital Coordinator of this site? Confirm its status | Camden | United States | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.